title: Emerging therapies offer new methods for treating rheumatoid arthritis.
abstract: The approvals of abatacept and rituximab have invigorated the already competitive market for biologic RA treatments. The new generation of RA therapies now reaching the market presents opportunities for patients - and challenges for payers.
authors: Vice President, Clinical Product Development.
authors: Steve
authors: S
authors: Russek